|Articles|January 18, 2022
Seamless Method Transfer to the Agilent 1290 Infinity II Bio LC System
Author(s)Agilent
Peptide-mapping analysis shows excellent performance and high method compatibility compared to the Agilent 1290 Infinity II LC System.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics
2
China Approves First Monthly Biologic for COPD
3
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
4
FUJIFILM Irvine Scientific Rebrands as FUJIFILM Biosciences
5